Search
for
Sort by
Research 151–180 of 1000+
- British Association of Dermatologists’ guidelines for the management of alopecia areata 2012
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Vitiligo - Part 2 - classification, histopathology and treatment
- Safety of dermatologic medications in pregnancy and lactation
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Review of treatment for alopecia totalis and alopecia universalis
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- The Diagnosis and Treatment of Hair and Scalp Diseases
- Molecular Genetics of the PI3K-AKT-mTOR Pathway in Genodermatoses: Diagnostic Implications and Treatment Opportunities
- Treatment options for alopecia: an update, looking to the future
- Cutaneous lupus erythematosus: clinico-pathologic correlation
- Hidradenitis Suppurativa
- Alopecia Areata: An Update on Treatment Options for Children
- Psoriatic Skin Lesions Induced by Certolizumab Pegol
- Trichoscopic Findings of Erosive Pustular Dermatosis of the Scalp Associated with Gefitinib
- NON-PSORALEN TREATMENT OF VITILIGO. PART II. LESS COMMONLY USED AND EXPERIMENTAL THERAPIES
- Hair and nail involvement in lupus erythematosus
- Patients with bullous skin disease in a high‐epidemic COVID‐19 area, Bergamo, Italy
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Frontal fibrosing alopecia: efficacy of treatment modalities
- Vitiligo: an evidence-based update. Report of the 13th Evidence Based Update Meeting, 23 May 2013, Loughborough, U.K.
- Fibrous Papule of the Face, Similar to Tuberous Sclerosis Complex-Associated Angiofibroma, Shows Activation of the Mammalian Target of Rapamycin Pathway: Evidence for a Novel Therapeutic Strategy?
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- The ‘bald’ phenotype (androgenetic alopecia) is caused by the high glycaemic, high cholesterol and low mineral ‘western diet’
- Tumor necrosis factor-induced alopecia: alternative pathology and therapy
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- An overview of management of drug-induced hair and nail disorders
- Understanding the Mechanism of Repigmentation in Vitiligo